Evidence map›Paper›PMID 41208113›Full record

ArticleImmunoHorizons2025

Normal macrophage signaling and gene expression in Rosa26 Cas9-expressing mice.

Monika D Hermann, Nuria Fernandez Perez, Assa Yeroslaviz, Peter J Murray

Abstract read
In one paragraph

Article in ImmunoHorizons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monika D HermannMax Planck Institute of Biochemistry, Martinsried, Germany.
Nuria Fernandez PerezMax Planck Institute of Biochemistry, Martinsried, Germany.
Assa YeroslavizMax Planck Institute of Biochemistry, Martinsried, Germany.
Peter J MurrayMax Planck Institute of Biochemistry, Martinsried, Germany.ORCID 0000-0001-6329-9802

Funding

Deutsche ForschungsgemeinschaftMax-Planck-Gesellschaft
6 · The paper itself

Abstract

Cas9-expression from the Rosa26 "safe harbor" locus are widely used for gene manipulation and Crispr-based screening. Recently, experimental evidence suggested that macrophages isolated from Rosa26-Cas9 mice may have signaling differences compared to control mice in terms of TRIF signaling downstream of TLR3 and TLR4. As we frequently use the Rosa26-Cas9 mice made by Feng Zhang (Cas9-FZ, Jackson Laboratory stock No. 026179), arguably the strain with the widest distribution and utilization, we were motivated to test macrophage signaling in these mice under our conventional conditions. We used different macrophage polarization and signaling conditions combined with RNA sequencing and measurement of TLR signaling by immunoblotting. Our results suggest that the Cas9-FZ mice bear no obvious defects in any commonly used macrophage signaling pathway. We document the differences in our macrophage culture techniques compared to Raychowdhury et al., which may aid in how individual laboratories use Cas9-expressing macrophages, especially for focused or genome-wide screening.

Indexed as

CRISPR-Associated Protein 9MacrophagesRNA, UntranslatedSignal TransductionAnimalsCRISPR-Cas SystemsMiceMice, Inbred C57BLMice, TransgenicToll-Like Receptor 3Toll-Like Receptor 4CRISPR-Associated Protein 9Gt(ROSA)26Sor non-coding RNA, mouseRNA, UntranslatedToll-Like Receptor 3Toll-Like Receptor 4Crispr/Cas9macrophagemacrophage polarizationRosa26signaling

Identifiers

PMID41208113
PMCPMC12597891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.